Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3.jpg)
Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net
![A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0003269718304263-fx1.jpg)
A FRET immunosensor for sensitive detection of CA 15-3 tumor marker in human serum sample and breast cancer cells using antibody functionalized luminescent carbon-dots and AuNPs-dendrimer aptamer as donor-acceptor pair - ScienceDirect
An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies | PLOS ONE
An impedimetric response study for the efficient detection of breast cancer specific biomarker CA 15-3 using a tin oxide thin film based immunoelectrode - Analytical Methods (RSC Publishing)
Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma | PLOS ONE
![Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics | npj Precision Oncology Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics | npj Precision Oncology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41698-021-00165-4/MediaObjects/41698_2021_165_Fig1_HTML.png)
Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics | npj Precision Oncology
![CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram CA15-3 tumor marker level over the course of the patient's treatment.... | Download Scientific Diagram](https://www.researchgate.net/profile/Garrett-Frampton/publication/318847012/figure/fig2/AS:631650916511761@1527608722402/CA15-3-tumor-marker-level-over-the-course-of-the-patients-treatment-Solid-line-CA15-3.png)